Originally published on Responsible Advertising for Patient Safety
Exposing the Litigation Financing, Advertising and Gaming Techniques That Are Threatening American Health Care
Blog Post | April 15, 2021
Blog Post | April 14, 2021
The medical technology community is made up of scientists, manufacturers, researchers, and engineers. Dr. Ajit Yoganathan is a unique combination of them all. Even so, Dr. Yoganathan – or Dr. Y to his colleagues and friends – would describe himself using an entirely different, but apt moniker: A conductor.
Promoting Equitable Access to Medical Technology: Considerations for MedTech Companies When Forming a Patient Assistance Program
Blog Post | March 23, 2021
The medical technology industry plays a pivotal role in improving the lives of people and communities across the world. Medtech companies employ thousands of researchers on the frontlines of medical discovery, researchers who draw on astounding knowledge and creativity to tackle every health challenge imaginable, including the ongoing COVID-19 pandemic.
April 22, 2021 | Online
Please join FDA and AdvaMed on Thursday, April 22 for a virtual Educational Meeting from 9:00 a.m. to 1:00 p.m. ET. The agenda includes important updates by FDA’s Office of Health Technology 6 (OHT6... Read More
April 27, 2021 | Online
Please note: At this time, we have reached capacity for The Value Assessment Workshop. We are looking into hosting a second event in the fall. Please click here to sign up for updates. The Value... Read More
May 6, 2021 |
The Digital MedTech Conference gathers the digital health community for an exploration of the evolving digital medtech landscape and the trends impacting the industry.
May 10, 2021 to May 12, 2021| Online
Please join us virtually from May 10-12, 2021 for the 13th Annual FDA/AdvaMed Medical Device Statistics Issues Conference. This annual conference brings together leading authorities from FDA,... Read More
San Diego— March 8, 2021 — iAssay, Inc., and DDTD (Drugs & Diagnostics for Tropical Diseases), a 501(c)(3) nonprofit, have signed a Memorandum of Understanding (MOU). DDTD is a mission-driven organization to develop accurate, affordable, mass-market treatments and diagnostics for low-resourced and under-served organizations. This step enables organizations to provide DDTD’s high performance COVID-19 serology tests along with automatic digitized reads that are transmitted simultaneously and...
SALT LAKE CITY--(BUSINESS WIRE)--O2TODAY ("O2TODAY"), a mask company that develops, manufactures and commercializes face masks for medical and non-medical uses, and SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”) (www.sintx.com), an original equipment manufacturer (OEM) of silicon nitride ceramics, announced today they have entered into a worldwide exclusive licensing agreement. O2TODAY expects to release their first consumer mask integrated with SINTX’s silicon nitride...
BOSTON, Jan. 20, 2021 -- Haemonetics Corporation (NYSE: HAE) ("Haemonetics"), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, today announced that it has entered into a definitive agreement to acquire privately-held Cardiva Medical, Inc., ("Cardiva") an industry-leading manufacturer of vascular closure systems based in Santa Clara, California. Under the terms of the agreement, Haemonetics will acquire Cardiva for an...
SBA Announces Recipients of Tibbetts Awards for Demonstrating Significant Economic and Social Impact from R&D Funding
Washington, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Today, the U.S. Small Business Administration announced 38 companies, seven organizations and 14 individuals as the winners of the prestigious Tibbetts Award for their accomplishments in creating cutting-edge technologies. The Tibbetts Awards, named after Roland Tibbetts, the founder of the SBIR Program, honors these awardees for the exceptional successes they achieved through SBA’s Small Business Innovation Research (SBIR) and Small Business...
Ortho’s VITROS® SARS-CoV-2 Antigen Test for Accurate, Mass-Scale COVID-19 Testing is the First Widely-Available, High-Volume Test to Receive FDA Emergency Use Authorization
Ortho’s VITROS® SARS-CoV-2 Antigen Test is the first high-volume COVID-19 antigen test to receive Food and Drug Administration (FDA) Emergency Use Authorization (EUA). With utility for mass-scale testing and same-day results for labs, Ortho’s latest COVID-19 solution can run up to 130 tests per hour. The test is run on Ortho’s high-volume VITROS® Systems, which are installed in over 5,600 laboratories around the world with 1,500 installed in the U.S. RARITAN, N.J. (January 12, 2021) – Ortho...
April 15, 2021 - 4:39pm
April 15, 2021 - 1:20pm
“I’m proud of the efforts made by AdvaMed and our members.” Former Board Chair Kevin Lobo shares insight into the p… https://t.co/3LTMsDJbFC